Trial Profile
Quantitative analysis of microbubble-enhanced ultrasound for diagnosis of sentinel lymph node metastasis of uterine cervical cancer and uterine body cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 29 Oct 2020
Price :
$35
*
At a glance
- Drugs Perflubutane (Primary)
- Indications Cancer metastases
- Focus Diagnostic use
- 26 Oct 2020 Status changed from recruiting to active, no longer recruiting.
- 14 May 2016 New trial record